Matrix metalloproteinase-9 and autoimmune diseases

Area of Science:

• Biochemistry and Molecular Biology
• Immunology
• Pathology

Background:

• Matrix metalloproteinases (MMPs) are zinc-dependent enzymes critical for regulating the extracellular matrix.
• These enzymes are vital for normal physiological processes including development and tissue remodeling.
• Dysregulation of MMPs is implicated in various pathological conditions such as inflammation, cardiovascular diseases, and cancer.

Purpose of the Study:

• To review the specific role of matrix metalloproteinase-9 (MMP-9) in the pathogenesis of diverse autoimmune diseases.
• To explore the regulatory mechanisms influencing MMP-9 expression in autoimmune contexts.
• To assess the therapeutic potential of targeting MMP-9 in autoimmune disease treatment.

Main Methods:

• Literature review focusing on studies investigating MMP-9 in autoimmune diseases.
• Analysis of MMP-9 expression patterns (up-regulation or down-regulation) in various autoimmune conditions.
• Examination of regulatory molecules affecting MMP-9 activity.

Main Results:

• MMP-9 is implicated in the pathogenesis of multiple autoimmune diseases, including systemic lupus erythematosus, Sjogren's syndrome, rheumatoid arthritis, and multiple sclerosis.
• MMP-9 exhibits variable expression, being either induced or suppressed by specific regulatory factors in disease states.
• The enzyme's involvement in disease progression underscores its significance.

Conclusions:

• MMP-9 plays a significant role, either primary or secondary, in the development and progression of various autoimmune diseases.
• The dynamic regulation of MMP-9 expression makes it a promising therapeutic target.
• Targeting MMP-9 offers a potential strategy for managing autoimmune diseases.